Vaughan Nelson Investment Management L.P. Has $67.32 Million Stock Position in Hawkins, Inc. $HWKN

Vaughan Nelson Investment Management L.P. lifted its stake in Hawkins, Inc. (NASDAQ:HWKN) by 35.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 473,752 shares of the specialty chemicals company’s stock after purchasing an additional 123,030 shares during the quarter. Vaughan Nelson Investment Management L.P. owned 2.27% of Hawkins worth $67,320,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. SkyOak Wealth LLC lifted its stake in Hawkins by 3.8% in the 1st quarter. SkyOak Wealth LLC now owns 2,374 shares of the specialty chemicals company’s stock worth $251,000 after acquiring an additional 88 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Hawkins by 20.4% during the 1st quarter. GAMMA Investing LLC now owns 531 shares of the specialty chemicals company’s stock worth $56,000 after purchasing an additional 90 shares in the last quarter. Hsbc Holdings PLC raised its stake in shares of Hawkins by 3.7% during the 1st quarter. Hsbc Holdings PLC now owns 2,976 shares of the specialty chemicals company’s stock worth $313,000 after purchasing an additional 105 shares in the last quarter. Focus Financial Network Inc. raised its stake in shares of Hawkins by 5.7% during the 2nd quarter. Focus Financial Network Inc. now owns 2,199 shares of the specialty chemicals company’s stock worth $312,000 after purchasing an additional 119 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its stake in shares of Hawkins by 118.8% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company’s stock worth $30,000 after purchasing an additional 152 shares in the last quarter. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins Trading Up 0.5%

NASDAQ:HWKN opened at $182.88 on Friday. Hawkins, Inc. has a 1-year low of $98.30 and a 1-year high of $185.50. The business’s 50-day moving average price is $171.87 and its two-hundred day moving average price is $144.30. The company has a current ratio of 2.31, a quick ratio of 1.45 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $3.82 billion, a price-to-earnings ratio of 45.04, a PEG ratio of 2.58 and a beta of 0.84.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.07. Hawkins had a return on equity of 18.35% and a net margin of 8.37%.The firm had revenue of $293.27 million for the quarter, compared to analyst estimates of $278.76 million. On average, equities analysts expect that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.4%. This is an increase from Hawkins’s previous quarterly dividend of $0.18. The ex-dividend date was Friday, August 15th. Hawkins’s dividend payout ratio is currently 18.72%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HWKN shares. Zacks Research downgraded Hawkins from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 22nd. Raymond James Financial started coverage on Hawkins in a research report on Thursday, July 24th. They issued a “market perform” rating on the stock. BWS Financial lifted their price target on Hawkins from $160.00 to $200.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Wall Street Zen cut Hawkins from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Hawkins in a research report on Saturday, September 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $162.50.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.